Search research articles

Search research articles

Related Experiment Videos

Renal cell carcinoma.

P A Godley¹, T E Stinchcombe

¹University of North Carolina at Chapel Hill, Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, 27599-7305, USA.

Current Opinion in Oncology

|May 18, 1999

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations.

ESMO open·2023

Same author

Lorlatinib in the treatment of anaplastic lymphoma kinase-positive non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Biomarker-directed molecularly targeted therapy: the importance of prospective evaluation.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Same author

Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses.

Clinical pharmacology and therapeutics·2014

Same author

The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: the North Carolina-Louisiana Prostate Cancer Project.

Journal of the National Medical Association·2013

Same author

Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026

Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026

Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026

Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026

Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026

Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dietary habits impact renal cell carcinoma risk. High intake of fried meats and poultry may increase risk, while fruits and vegetables show a protective effect. Molecular markers may aid in treatment decisions for kidney cancer.

Area of Science:

Oncology
Nephrology
Epidemiology

Background:

Known renal cell carcinoma (kidney cancer) risk factors include hypertension, obesity, and tobacco use.
Dietary patterns are increasingly recognized as significant contributors to cancer development.
Understanding modifiable risk factors is crucial for public health initiatives.

Purpose of the Study:

To investigate the association between dietary habits and the risk of developing renal cell carcinoma.
To explore the potential prognostic value of molecular markers in kidney cancer patients.
To review current treatment strategies for localized and metastatic renal cell carcinoma.

Main Methods:

Review of epidemiological data on diet and renal cell carcinoma incidence.

Related Experiment Videos

Analysis of molecular markers for prognostic assessment in kidney cancer.

Evaluation of treatment outcomes for surgery and systemic therapies (cytokines).

Main Results:

High consumption of fried/sautéed meats and poultry is associated with increased renal cell carcinoma risk.
Increased intake of fruits and vegetables demonstrates a protective effect against kidney cancer.
Cell proliferation markers show potential prognostic value for guiding aggressive therapy in kidney cancer patients.

Conclusions:

Dietary modifications, emphasizing fruits and vegetables while limiting certain meats, may reduce renal cell carcinoma risk.
Molecular markers could personalize treatment strategies for kidney cancer.
Surgery remains the primary treatment for localized disease; cytokine therapy offers limited response rates with significant side effects for advanced kidney cancer.